CIPLA
|
The Current P/S Ratio of CIPLA is 4.39.
Share Price | ₹1,497.3 | Jul 02,2025 |
Market Cap | ₹120,947.9 Cr | |
Sales-TTM | ₹27,547.6 Cr | TTM-Consolidated Results |
Price/Sales | 4.39x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of CIPLA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹120,947.9 Cr] as on Jul 02,2025
(/) Sales [ ₹27,547.6 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.39x ]
Thus, for CIPLA , the investors are currently willing to pay '4.39 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of CIPLA !
The chart below summarizes the trend in P/S Ratio of CIPLA over the last five years.
Historical PS (Price/Sales) ratio chart of CIPLA
PS Ratio Performance Analysis for CIPLA
- CIPLA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.86x.
- CIPLA 's operated at median p/e ratio of 3.78x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, CIPLA 's p/e ratio peaked in Mar2024 at 4.68x.
- CIPLA 's p/e ratio hit its five-year low in Mar2023 of 3.19x.
How does CIPLA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
CIPLA | 27,547.6 | 4.39 | 120,947.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 52,578.4 | 7.66 | 402,584.0 |
DIVIS LABORATORIES LTD | 9,360.0 | 19.46 | 182,147.0 |
TORRENT PHARMACEUTICALS LTD | 11,516.0 | 9.84 | 113,325.0 |
DR REDDYS LABORATORIES LTD | 32,643.9 | 3.25 | 106,138.0 |
MANKIND PHARMA LTD | 12,279.3 | 8.02 | 98,491.5 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.31 | 100,176.0 |
LUPIN LTD | 22,707.9 | 3.96 | 89,863.5 |
AUROBINDO PHARMA LTD | 31,723.7 | 2.12 | 67,242.3 |
ABBOTT INDIA LTD | 6,409.2 | 11.73 | 75,200.0 |
ALKEM LABORATORIES LTD | 12,964.5 | 4.49 | 58,258.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs CIPLA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.12x |
Max industry PS | 19.46x |
Median industry PS | 4.49x |
Average industry PS | 7.20x |
You may also like the below Video Courses